Juno - About the company
Juno is a seed company based in Mississauga (Canada), founded in 2009 by Mike Armstrong. It operates as a Manufacturer of biosimilars drugs. Juno has raised an undisclosed amount in funding. The company has 46 active competitors, including 1 funded and 5 that have exited. Its top competitors include companies like AmerisourceBergen, Pharmasave and Andone Pharma.
Company Details
- Website
- www.junopharm.ca
- Email ID
- *****@junopharm.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2009
Location
Mississauga, Canada
Stage
Seed
Latest Funding Round
Investors
Ranked
2nd among 46 active competitors
Similar Companies
Legal entities associated with Juno
Juno is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Novisto Inc. CIN: 11731548 , Canada, Active | - | - | - |
Sign up to download Juno's company profile
Juno's funding and investors
Juno has raised funding over 1 round. Its latest funding round was a Seed round on Feb 24, 2022 for $*****. 1 investor participated in its latest round. Juno has 2 institutional investors.
Here is the list of recent funding rounds of Juno:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 24, 2022 | 9026737 | Seed | 4480580 | 6986531 | 1934360 | 9621497 |
Access funding benchmarks and valuations. Sign up today!View details of Juno's funding rounds and investors
Juno's founders and board of directors
Founder? Claim ProfileThe founders of Juno is Mike Armstrong. Mark Mantel is the CEO of Juno.
Here are the details of Juno's key team members:
- Mike Armstrong: Founder & President of Juno and founder of 1 other company.
- Mark Mantel: CEO of Juno.
Juno's Board of Directors
Juno's board has 6 active members. James Gale, Craig Podolsky, Ian Jacobson, Jack M. Kay, Viswanath Chebrol and Allan Mandelzys are independent board members.Here is the list of Juno's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 1y 5m | |
apzepxg | Independent board member | - | Current | 7y 8m |
zgepfmw | Independent board member | - | Current | 9y 3m |
jiwxolx | Independent board member | - | Current | 7y 4m |
asujtrc | Independent board member | - | Current | 7y 2m |
wxecynt | Independent board member | - | Current | 5y 3m |
View details of Juno's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Juno's Competitors and alternates
Top competitors of Juno include AmerisourceBergen, Pharmasave and Andone Pharma. Here is the list of Top 10 competitors of Juno, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AmerisourceBergen 1985, Chesterbrook (United States), Public | Drug Corporation | - | 68/100 | |
2nd | Manufacturer of biosimilars drugs | - | 41/100 | ||
3rd | Pharmasave 1981, Langley (Canada), Unfunded | Diversified pharmaceutical distributor | - | - | 27/100 |
4th |  Andone Pharma 2018, Oakville (Canada), Acquired | Developer of pharmaceutical products and medical devices for healthcare systems | - | - | 26/100 |
5th | Kohl And Frisch 1916, Concord (Canada), Unfunded | Provider of distribution and logistics services for the healthcare industry | - | - | 23/100 |
6th | Distributor of pharmaceutical products | - | - | 22/100 | |
7th |  Columbia Laboratories Canada 2001, Ottawa (Canada), Unfunded | Provider of high-quality OTC pharmaceutical products | - | - | 21/100 |
8th |  SkyCap Financial 2013, Kingston (Canada), Unfunded | Wholesale pharmaceutical products exporter and distributor | - | - | 21/100 |
9th | CellChem Pharmaceuticals 2010, Canada, Unfunded | A leading supplier of affordable, high-quality generic and branded pharmaceuticals | - | - | 21/100 |
10th |  Dermabeauty 2016, Toronto (Canada), Unfunded | Distributor of premium skincare products for professional and at-home use | - | - | 20/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Juno's competitors? Click here to see the top ones
Juno's Investments and acquisitions
Juno has made 2 investments in FluidAI and Speciality European Pharma and acquired Omega Laboratories.Here is the list of these investments and acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 10, 2023 | Investments | 2014 | Kitchener (Canada) | |
May 15, 2023 | Acquisition | 1999 | Mogadore (United States) | |
May 2016 | Investments | 2006 | London (United Kingdom) |
Want to know more about where corporates are investing? Sign up today!Reports related to Juno
Here is the latest report on Juno's sector:
News related to Juno
Filter this listMedia has covered Juno for a total of 3 events in the last 1 year.
•
LSL Pharma Group to Acquire Juno OTC in $5M Deal, Announces $11M Debenture OfferingFinancial Times•Dec 17, 2025•LSL Pharma Group, Juno Pharmaceuticals, Bloom Burton, Juno
•
TQ Therapeutics Acquires Juno Therapeutics GmbHB3Cnewswire•May 28, 2025•TQ Therapeutics, Juno, Bristol-Myers Squibb
•
CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.Financial Post•Apr 25, 2025•CPOINT Capital, Juno, Conavi
•
Conavi Medical Corp. Announces $20M Public Offering ClosingGlobeNewswire•Apr 23, 2025•Conavi, Juno, CPOINT Capital
•
•
FluidAI Medical Raises $15M in Series A FundingFinSMEs•Oct 11, 2023•FluidAI, SOSV, Graphene Ventures, Boutique Venture Partners and 7 others
•
Juno Pharmaceuticals acquires Omega Laboratories, propelling the Canadian pharmaceutical industry forwardBusiness Wire•May 15, 2023•Juno, Omega Laboratories
•
Juno Pharmaceuticals Acquires Omega Laboratories, Propelling Canada’s Pharmaceutical Industry ForwardBusiness Wire•May 15, 2023•Juno, Omega Laboratories, omegalab.in
•
Juno Pharmaceuticals Receives Approval to Import Ketamine, Providing Immediate Relief for Hospitals Across CanadaBusiness Wire•May 04, 2023•Juno
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Juno
Explore our recently published companies
- New Space - United States based, Unfunded company
- Neo Logistics (Extending the Limits) - 2007 founded, Unfunded company
- All Season Contracting - Canada based, 2003 founded, Unfunded company
- Vsthiraabioscience - Unfunded company
- Trapez Finance - Israel based, 2017 founded, Unfunded company
- Implant Growth - Unfunded company
